logo
メッセージを送る
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
製品
製品
家へ > 製品 > 化学中間物 > 2-hydroxy-3-methoxy-3,3-diphenylpropanoic Acid CAS 178306-51-9

2-hydroxy-3-methoxy-3,3-diphenylpropanoic Acid CAS 178306-51-9

製品詳細

起源の場所: 中国

ブランド名: Sunshine

証明: ISO,COA

モデル番号: 178306-51-9

支払いと送料の条件

最小注文数量: 交渉

価格: 交渉可能

パッケージの詳細: アルミ製の紙袋,ドラム

受渡し時間: 7〜15日

支払条件: T/T,L/C,D/A,ウェスタンユニオン

供給の能力: トン

最高 の 価格 を 入手 する
CAS番号::
178306-51-9
外見::
白い固体
分子式::
C16H16O4
分子重量::
272.296
EINECS番号::
605-820-8
MDL NO::
MFCD13152279
CAS番号::
178306-51-9
外見::
白い固体
分子式::
C16H16O4
分子重量::
272.296
EINECS番号::
605-820-8
MDL NO::
MFCD13152279
2-hydroxy-3-methoxy-3,3-diphenylpropanoic Acid CAS 178306-51-9

Product Description:

Product Name: 2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid CAS 178306-51-9

 

 

 

 

 

 

 

Synonyms:

hydroxymethoxydiphenylpropanoicacid;

rac-2-hydroxy-3-methoxy-3,3-diphenylpropionic acid;

 

 

 

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance :white solid

Assay :≥99.0%

Density:1.25 g/cm3

Boiling Point: 430.3℃ at 760 mmHg

Flash Point:158.4℃

 

 

 

 

 

 

 

3-methoxy-2-hydroxy-3,3-diphenylpropionic acid is used to Ambrisentan intermediate.

Anrisentan is a selective endothelin receptor antagonist, which has the effects of reducing endogenous vasoconstriction, antiproliferative and anti-inflammatory. Anrisentan is a specific endothelin receptor A (ETA receptor) inhibitor developed by Gilead Science Company. It is a highly selective ETA receptor antagonist that can block the binding of ET and ETA, thereby blocking ETA-mediated pulmonary vasoconstriction and smooth muscle cell proliferation.

 

 

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.